SUBSCRIBE
SUBSCRIBE
Pharm Country

ZIOPHARM Oncology, Inc. to Present at Upcoming Investor Conferences

February 21, 2012 | 
1 min read
NEW YORK, Feb. 21, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer of ZIOPHARM, will present at the following investor conferences:
Events
MORE ON THIS TOPIC
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
October 29, 2025
 · 
3 min read
 · 
Heather McKenzie
Highway in Phoenix, Arizona leading toward downtown at sunset
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
 · 
4 min read
 · 
Heather McKenzie